Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Speakers' Corner 3: VASC DISEASE I

10:15 - 11:45 | 21 September | Room: Speaker Corner.

Back to Previous

10:15Functional and structural characteristics in patients with diabetic macular oedema after switching from Ranibizumab to Aflibercept treatment. One year results in real world settings.
H. Clarke United Kingdom
10:20Feasibility study for the introduction of automated retinal image analysis software into routine high volume diabetic retinopathy screening in the United Kingdom.
C. Egan United Kingdom
10:25Thickening of the choroid in children with type 1 diabetes mellitus and no diabetic retinopathy
M. Niestrata-Ortiz United Kingdom
10:30Retinal nerve fiber layer thickness in diabetic patients
S. Dundar Turkey
10:35Real world data of 20,066 cataract operations – Incidence of post-operative macular oedema in diabetic patients with or without diabetic retinopathy.
M. Teo United Kingdom
10:40Fluocinolone acetonide intravitreal implant (Iluvien) as the treatment for chronic macular oedema (MO) in Retinal vein occlusions (RVO): case-series of one year result
V. Felcida United Kingdom
10:45The effects of hyperbaric oxygen therapy on diabetic retinopathy
A. Maalej Tunisia
10:50Nutrition matters in diabetic macular edema (DME) – or does it? A clinical analysis of the evidence supporting the use of food interventions in a combined approach to treating DME
C. Wright United Kingdom
10:55Outcomes in different subtypes of diabetic macular edema treated with ozurdex: anatomical and functional results in cystoid macular edema
V. Castro-Navarro Spain
11:00Diabetic retinopathy and maculopathy levels in an English county
A. Dale United Kingdom
11:05Intravitreal Bevacizumab as an adjunct to vitrectomy for vitreous hemorrhage in patients with proliferative diabetic retinopathy
I. Damian Romania
11:10DIVERSE: Non-inferiority of ranibizumab administered at the discretion of the investigator to standard care (pro re nata administration) in diabetic macula edema: A 12-month, randomized, controlled, VA-assessor blinded, multicenter, phase IV trial
G. Spital Germany
11:15Relationship between metamorphopsia and inner retinal structure following intravitreal ranibizumab injection for branch retinal vein occlusion
Y. Sugiura Japan
11:20OCT in diabetic telemedicine screening
C. Arruabarrena Spain
11:25Limiting factors of improvement of visual acuity after half-fluence photodynamic therapy in patients with chronic central serous chorioretinopathy
V. Matuskova Czech Republic
11:30What is the efficacy of oral sucrose and non-nutritive sucking on pain response in retinopathy of prematurity screening examinations.
C. Papandreou United Kingdom
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait